このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Physical Frailty Intervention for Older Adults With Hypertension and Physical Frailty (PFIM)

2026年11月12日 更新者:Dong Yuan

Development and Evaluation of Physical Frailty Intervention Module for Older Adults With Hypertension in Shandong Province, China

Physical frailty is a common health concern among older adults with hypertension and may contribute to reduced physical function, loss of independence, and poorer quality of life. This study aims to evaluate the effectiveness of a 12-week nurse-led Physical Frailty Intervention Module (PFIM) among community-dwelling older adults with hypertension and physical frailty in Shandong Province, China.

This nonrandomized controlled study will recruit 124 participants aged 60 years or older from three primary healthcare institutions. Two institutions will be assigned to the intervention group, which will receive the PFIM in addition to usual care, while one institution will serve as the control group and provide usual care only.

The PFIM is based on the Health Action Process Approach (HAPA) and combines simplified Baduanjin exercise, basic nutrition guidance, hypertension self-management education, and behavioral support. The intervention includes nurse-led group sessions, individualized home-based exercise, and follow-up support over 12 weeks.

Physical frailty will be the primary outcome. Physical performance, nutritional status, health literacy, perceived social support, depressive symptoms, and quality of life will be assessed as secondary outcomes at baseline and after 12 weeks.

調査の概要

状態

まだ募集していません

条件

介入・治療

詳細な説明

This study is the third phase of a multiphase research project involving the development, validation, and evaluation of a Physical Frailty Intervention Module (PFIM) for older adults with hypertension and physical frailty.

A pragmatic, two-arm, nonrandomized controlled quasi-experimental design will be used. The study will be conducted at three primary healthcare institutions in Yanzhou District, Jining, Shandong Province, China. Two institutions will be allocated to the intervention group and one to the control group to minimize contamination. The planned sample size is 124 participants, with 62 participants per group.

The 12-week PFIM is informed by the Health Action Process Approach (HAPA) and delivered by trained nurses. It comprises three stages:

Weeks 1-4 focus on motivation and participation preparation through weekly face-to-face group education sessions addressing physical frailty, hypertension, nutrition, exercise safety, and behavioral change.

Weeks 5-8 emphasize action planning and behavior initiation through weekly group sessions and home-based simplified Baduanjin practice two to three times weekly for 15-20 minutes per session.

Weeks 9-12 focus on behavior maintenance through continued home practice, progressing toward 20-30 minutes per session when appropriate, with group sessions in Weeks 9 and 12 and telephone or WeChat follow-up in Weeks 10 and 11.

Standing or seated simplified Baduanjin exercises will be assigned according to participants' physical performance and clinical safety assessments. The control group will receive usual hypertension care without the structured PFIM.

The primary outcome is physical frailty severity, measured using the FRAIL Scale. Secondary outcomes include physical performance (SPPB), nutritional status (MNA-SF), health literacy (HLS-SF12), perceived social support (PSSS), depressive symptoms (GDS-15), and quality of life (OPQOL-brief). Outcomes will be assessed at baseline and immediately after the 12-week intervention.

研究の種類

介入

入学 (推定)

124

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Shandong
      • Jining、Shandong、中国、272100
        • Caohe Town Health Center
        • コンタクト:
      • Jining、Shandong、中国、272100
        • Jiuxianqiao Subdistrict Community Health Service Center
        • コンタクト:
      • Jining、Shandong、中国、272100
        • Yandian Central Health Center
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

60年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Aged 60 years or older.
  • Physician-diagnosed hypertension or current use of physician-prescribed antihypertensive medication.
  • Physical frailty, defined as a FRAIL Scale score of 3 or higher.
  • Community-dwelling and residing within the catchment area of one of the participating primary healthcare institutions.
  • Adequate cognitive and communication abilities to understand study procedures, communicate in Mandarin or the local dialect, complete questionnaires with or without assistance, and provide written informed consent.
  • Medically stable and considered fit for light-to-moderate physical activity by the treating physician.

Exclusion Criteria:

  • Major acute illness requiring hospitalization within the preceding three months, such as acute myocardial infarction, acute stroke, or acute decompensated heart failure.
  • Current participation in another structured health promotion, rehabilitation, or exercise program.
  • Disabling stroke, active or advanced cancer, advanced heart failure, severe chronic obstructive pulmonary disease, or another serious medical condition that makes participation unsafe or substantially limits life expectancy.
  • Adjusted Montreal Cognitive Assessment (MoCA) score below the prespecified education-specific thresholds: <14 for illiterate participants, <15 for those with primary-school education, or <21 for those with junior-secondary education or above. One additional point is applied for fewer than 12 years of education, up to a maximum score of 30.
  • Major visual, hearing, speech, or other communication impairment that prevents meaningful participation.
  • Severe uncontrolled psychiatric disorder, major neurocognitive disorder, or end-stage disease that prevents comprehension, cooperation, or safe participation.
  • Any other condition considered medically unsuitable for participation by the treating physician.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:非ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:PFIM Intervention Group

Participants in this group will receive the 12-week nurse-led Physical Frailty Intervention Module (PFIM) in addition to usual primary healthcare for hypertension. The intervention includes simplified Baduanjin exercise, nutrition guidance, hypertension self-management education, individualized action planning, self-monitoring, and follow-up support.

The Physical Frailty Intervention Module (PFIM) is a 12-week nurse-led behavioral intervention based on the Health Action Process Approach (HAPA). During Weeks 1-4, participants attend weekly group education sessions on physical frailty, hypertension, nutrition, and exercise safety. During Weeks 5-8, participants attend weekly group sessions and begin home-based simplified Baduanjin practice 2-3 times per week for 15-20 minutes per session. During Weeks 9-12, home practice continues, progressing toward 20-30 minutes per session as tolerated, with group sessions in Weeks 9 and 12 and telephone or WeChat follow-up in Weeks 10 and 11. Standing or seated exercises are assigned according to physical performance and safety assessments. The intervention is provided in addition to usual hypertension care.

介入なし:Usual Care Control Group

Participants in the control group will receive usual primary healthcare for hypertension, including routine blood pressure monitoring, medication management, general lifestyle advice, and regular follow-up. No structured Physical Frailty Intervention Module (PFIM) will be provided during the 12-week study period.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Physical Frailty Severity Measured by the FRAIL Scale
時間枠:Baseline (Week 0) and Week 12

Physical frailty will be assessed using the five-item FRAIL Scale, covering fatigue, resistance, ambulation, illnesses, and weight loss. Each item is scored 0 or 1, yielding a total score from 0 to 5. Higher scores indicate greater frailty severity. Change will be calculated as the Week 12 score minus the baseline score.

Baseline (Week 0) and Week 12

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Physical Performance Measured by the Short Physical Performance Battery (SPPB)
時間枠:Baseline (Week 0) and Week 12

Physical performance will be assessed using the Short Physical Performance Battery (SPPB), comprising balance, 4-meter gait speed, and repeated chair stands. Each component is scored from 0 to 4, yielding a total score from 0 to 12. Higher scores indicate better physical performance. Change is the Week 12 score minus the baseline score.

Baseline (Week 0) and Week 12
Change in Nutritional Status Measured by the Mini Nutritional Assessment-Short Form (MNA-SF)
時間枠:Baseline (Week 0) and Week 12

Nutritional status will be assessed using the six-item Mini Nutritional Assessment-Short Form (MNA-SF). Total scores range from 0 to 14, with higher scores indicating better nutritional status. Change is the Week 12 score minus the baseline score.

Baseline (Week 0) and Week 12
Change in Health Literacy Measured by the Health Literacy Survey-Short Form 12 (HLS-SF12)
時間枠:Baseline (Week 0) and Week 12

Health literacy will be measured using the 12-item Health Literacy Survey-Short Form (HLS-SF12), covering healthcare, disease prevention, and health promotion. Responses are converted to a standardized index ranging from 0 to 50. Higher scores indicate better health literacy. Change is the Week 12 index minus the baseline index.

Baseline (Week 0) and Week 12
Change in Perceived Social Support Measured by the Perceived Social Support Scale (PSSS)
時間枠:Baseline (Week 0) and Week 12

Perceived social support will be assessed using the 12-item Perceived Social Support Scale (PSSS), covering support from family, friends, and significant others. Each item is rated from 1 to 7, giving a total score from 12 to 84. Higher scores indicate greater perceived social support. Change is the Week 12 score minus the baseline score.

Baseline (Week 0) and Week 12
Change in Depressive Symptoms Measured by the 15-Item Geriatric Depression Scale (GDS-15)
時間枠:Baseline (Week 0) and Week 12

Depressive symptoms will be assessed using the 15-item Geriatric Depression Scale (GDS-15). Each item is scored 0 or 1, giving a total score from 0 to 15. Higher scores indicate more severe depressive symptoms. Change is the Week 12 score minus the baseline score.

Baseline (Week 0) and Week 12
Change in Quality of Life Measured by the Brief Older People's Quality of Life Questionnaire (OPQOL-brief)
時間枠:Baseline (Week 0) and Week 12

Quality of life will be assessed using the 13-item Brief Older People's Quality of Life Questionnaire (OPQOL-brief). Items are scored on a five-point scale and coded so that higher scores indicate better quality of life. Total scores range from 13 to 65. Change is the Week 12 score minus the baseline score.

Baseline (Week 0) and Week 12

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年11月20日

一次修了 (推定)

2027年3月31日

研究の完了 (推定)

2027年3月31日

試験登録日

最初に提出

2026年11月12日

QC基準を満たした最初の提出物

2026年11月12日

最初の投稿 (実際)

2026年11月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月18日

QC基準を満たした最後の更新が送信されました

2026年11月12日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • USM/JEPeM/KK/26040291

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant-level data will not be shared outside the study team due to participant privacy and confidentiality considerations.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。